Optimind Pharma (XCNQ:OMND) EBITDA Margin % : -274.07% (As of Nov. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Optimind Pharma EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Optimind Pharma's EBITDA for the three months ended in Nov. 2023 was C$-0.07 Mil. Optimind Pharma's Revenue for the three months ended in Nov. 2023 was C$0.03 Mil. Therefore, Optimind Pharma's EBITDA margin for the quarter that ended in Nov. 2023 was -274.07%.

Optimind Pharma EBITDA Margin % Historical Data

The historical data trend for Optimind Pharma's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimind Pharma EBITDA Margin % Chart

Optimind Pharma Annual Data

Trend

Feb22

Feb23

EBITDA Margin %

-1,746.47

Optimind Pharma Quarterly Data
	Jun21	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23
EBITDA Margin %	Get a 7-Day Free Trial			-463.33	-4,539.53	-900.00	-551.85	-274.07

Competitive Comparison of Optimind Pharma's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Optimind Pharma's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Optimind Pharma's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Optimind Pharma's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Optimind Pharma's EBITDA Margin % falls into.

Optimind Pharma EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Optimind Pharma's EBITDA Margin % for the fiscal year that ended in Feb. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Feb. 2023 )	/	Revenue (A: Feb. 2023 )
	=	-2.969	/	0.17
	=	-1,746.47 %

Optimind Pharma's EBITDA Margin % for the quarter that ended in Nov. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Nov. 2023 )	/	Revenue (Q: Nov. 2023 )
	=	-0.074	/	0.027
	=	-274.07 %

Optimind Pharma (XCNQ:OMND) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Optimind Pharma EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Optimind Pharma's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Optimind Pharma (XCNQ:OMND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimind Pharma Corp (XCNQ:OMND) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

3000 - 77 King Street West, TD Centre, North Tower, PO Box 95, Toronto, ON, CAN, M5K 1G8

Website

https://www.optimindpharma.com

Optimind Pharma Corp is an emerging provider of psychedelic therapies for the masses. It helps people suffering from PTSD, Anxiety, Depression, and other mental illnesses and disabilities by providing ketamine-assisted-treatment and other psychedelic-enhanced-psychotherapy modalities.

Optimind Pharma (XCNQ:OMND) Headlines

No Headlines